Funding benchmark · last 12 months
From 60 seed rounds announced in Biotech over the last twelve months, each read from a named source. Half of them raised between $3.3M and $13M.
60 rounds counted · recounted nightly
The trend
From $5.5M in 2024 Q4 to $5.0M in 2026 Q3. Quarters with fewer than five rounds are left blank.
Who leads
The firms that led the most seed rounds in Biotech this year.
Recent examples
ALLOX29 Oct 2026 · Asabys$11M+43%
DropGenie26 Oct 2026 · Skeleton Key$5.0M-32%
IMIO20 Oct 2026 · Sofinnova Partners$12M+63%
Giraffe Bio13 Oct 2026 · Orion Mine Finance$6.4M-13%
Aptadir Therapeutics29 Sept 2026 · 4BIO Capital$46M+519%
AbTx18 Sept 2026 · Not named$1.9M-74%
Eterna Regeneratives16 Sept 2026 · Hoxton Ventures$4.0M-46%
Magnitude Biosciences15 Sept 2026 · Northstar Ventures$1.8M-76%They come from announced rounds. Large rounds are almost always announced and many small ones never are, so the true typical round is probably a little smaller than shown, most of all at pre-seed and seed. Every round behind them is in the record with its source. How we read rounds.
Other stages in Biotech
Seed elsewhere
See who leads rounds like yours,
and check your raise before you pitch.
The median is $7.3M, from 60 seed rounds announced in Biotech in the last twelve months. Half of them raised between $3.3M and $13M; one in ten raised more than $22M.
Rounds announced in the last twelve months with a stated amount and stage, each read from a named article or filing. A page is only published where at least 30 rounds stand behind it.
Towards larger rounds, yes. Big rounds are announced; many small ones never are. So the true typical round is probably a little smaller than the figure here, especially at pre-seed and seed.
The figures are recounted from the record every night, as new rounds are read.